Dohoun L - Search Results

1

Two-months-off, four-months-on antiretroviral regimen increases the risk of resistance, compared with continuous therapy: a randomized trial involving West African adults.

Danel C, Moh R, Chaix ML, Gabillard D, Gnokoro J, Diby CJ, Toni T, Dohoun L, Rouzioux C, Bissagnene E, Salamon R, Anglaret X; Trivacan ANRS 1269 Trial Group. Danel C, et al. Among authors: dohoun l. J Infect Dis. 2009 Jan 1;199(1):66-76. doi: 10.1086/595298. J Infect Dis. 2009. PMID: 18986246 Clinical Trial.

2

[Bacillary angiomatosis in an adult infected with HIV-1 at an early stage of immunodepression in Abidjan, Côte d'Ivoire].

Minga KA, Gberi I, Boka MB, Gourvellec G, Abo Y, Dohoun L, Abe H, Ekra D, Bonard D, Danel C, Huet C, Salamon R, Bondurand A, N'Dri-Yoman T, Anglaret X. Minga KA, et al. Among authors: dohoun l. Bull Soc Pathol Exot. 2002 Mar;95(1):34-6. Bull Soc Pathol Exot. 2002. PMID: 12012962 French.

3

Behavior assessment of blood donors facing the risk of HIV infection, Abidjan, Cotê D'Ivoire, 2001-2002.

Minga AK, Huët C, Dohoun L, Abo Y, Bonard D, Gourvellec G, Coulibaly A, Konaté S, Dabis F, Salamon R; ANRS 1220 PRIMO-CI Study Group. Minga AK, et al. Among authors: dohoun l. J Acquir Immune Defic Syndr. 2005 Apr 15;38(5):618-21. doi: 10.1097/01.qai.0000141221.20346.65. J Acquir Immune Defic Syndr. 2005. PMID: 15793375

4

Progression to WHO criteria for antiretroviral therapy in a 7-year cohort of adult HIV-1 seroconverters in Abidjan, Côte d'Ivoire.

Minga A, Danel C, Abo Y, Dohoun L, Bonard D, Coulibaly A, Duvignac J, Dabis F, Salamon R, Anglaret X; ANRS 1220 Study Group. Minga A, et al. Among authors: dohoun l. Bull World Health Organ. 2007 Feb;85(2):116-23. doi: 10.2471/blt.06.032292. Bull World Health Organ. 2007. PMID: 17308732 Free PMC article.

5

HIV-1 DNA in peripheral blood mononuclear cells is strongly associated with HIV-1 disease progression in recently infected West African adults.

Minga AK, Anglaret X, d' Aquin Toni T, Chaix ML, Dohoun L, Abo Y, Coulibaly A, Duvignac J, Gabillard D, Rouet F, Rouzioux C. Minga AK, et al. Among authors: dohoun l. J Acquir Immune Defic Syndr. 2008 Jul 1;48(3):350-4. doi: 10.1097/QAI.0b013e3181775e55. J Acquir Immune Defic Syndr. 2008. PMID: 18545149

6

Risk behaviors in volunteer blood donors who seroconverted for HIV, Abidjan, Côte d'Ivoire 1997 to 2005.

Minga A, Dohoun L, Abo Y, Coulibaly A, Konaté S, Ouattara HP, N'guessan BK, Dabis F, Salamon R, Lewden C; ANRS 1220 PRIMO-CI Study Group. Minga A, et al. Among authors: dohoun l. Transfusion. 2010 Apr;50(4):888-93. doi: 10.1111/j.1537-2995.2009.02499.x. Epub 2009 Nov 20. Transfusion. 2010. PMID: 19951316 Free article.

7

Short communication: Severe symptomatic hyperlactatemia among HIV type 1-infected adults on antiretroviral therapy in Côte d'Ivoire.

Minga A, Lewden C, Dohoun L, Abo Y, Emieme A, Coulibaly A, Salamon R, Eholié S, Anglaret X, Danel C; ANRS 1220 Primo-CI Study Group. Minga A, et al. Among authors: dohoun l. AIDS Res Hum Retroviruses. 2010 Sep;26(9):991-5. doi: 10.1089/aid.2009.0309. AIDS Res Hum Retroviruses. 2010. PMID: 20707728 Free PMC article.

8

CD4 cell eligibility thresholds: an analysis of the time to antiretroviral treatment in HIV-1 seroconverters.

Minga AK, Lewden C, Gabillard D, Bomisso GI, Toni TD, Emième AA, Yapo V, Inwoley A, Salamon R, Anglaret X; Agence Nationale de Recherches sur le Sida (ANRS) 1220 Primo-CI Study Group. Minga AK, et al. AIDS. 2011 Mar 27;25(6):819-23. doi: 10.1097/QAD.0b013e32834625d3. AIDS. 2011. PMID: 21412060 Free PMC article.

9

AIDS and non-AIDS morbidity and mortality across the spectrum of CD4 cell counts in HIV-infected adults before starting antiretroviral therapy in Cote d'Ivoire.

Anglaret X, Minga A, Gabillard D, Ouassa T, Messou E, Morris B, Traore M, Coulibaly A, Freedberg KA, Lewden C, Ménan H, Abo Y, Dakoury-Dogbo N, Toure S, Seyler C; ANRS 12222 Morbidity/Mortality Study Group. Anglaret X, et al. Clin Infect Dis. 2012 Mar 1;54(5):714-23. doi: 10.1093/cid/cir898. Epub 2012 Feb 4. Clin Infect Dis. 2012. PMID: 22173233 Free PMC article.

10

Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa.

Pantazis N, Morrison C, Amornkul PN, Lewden C, Salata RA, Minga A, Chipato T, Jaffe H, Lakhi S, Karita E, Porter K, Meyer L, Touloumi G; CASCADE Collaboration in EuroCoord and ANRS 1220 Primo-CI Study Group. Pantazis N, et al. PLoS One. 2012;7(3):e32369. doi: 10.1371/journal.pone.0032369. Epub 2012 Mar 6. PLoS One. 2012. PMID: 22412867 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters